Author(s)Ophthalmology Times Staff June 17, 2026 Fact checked by: Lucia Gambuzza Key Takeaways Belite’s rolling NDA for tinlarebant advances under Breakthrough Therapy Designation, with Fast Track, […]
Article source: EyeWorld.org Nanoscope Therapeutics announced publication of positive results from its Phase 2 trial online in the journal eClinical Medicine ahead of print in The Lancet. The trial,
Phase 2 Trial is the ‘First and Only’ to Show Vision Improvement for Stargardt Disease Read More »
From the Foundation Fighting Blindness January 2025 SPLICEBIO RECEIVES FDA CLEARANCE TO LAUNCH CLINICAL TRIAL FOR STARGARDT DISEASE PROTEIN SPLICING THERAPY SpliceBio, a genetic medicines
Stargardt Disease Research Advances Read More »